Indian company launches drug to treat mild, moderate Covid-19 patients; another gunfight breaks out in Kashmir

  • 📰 staronline
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 75%

Italia Notizia Notizia

Italia Ultime Notizie,Italia Notizie

MUMBAI (Xinhua): Glenmark Pharmaceuticals has become the first Indian company to launch anti-viral drug Favipiravir for the treatment of mild to moderate Covid-19 patients in the domestic market following the manufacturing approval from the drug regulator, a company statement said.

Launched under the brand name FabiFlu, the oral drug will be available as a prescription-based medication for US$1.35 per tablet.

It offers rapid reduction in viral load within four days and has shown clinical improvement of up to 88 per cent in mild to moderate Covid-19 cases, it added. In another development, a gunfight between militants and government forces broke out Sunday in restive Indian-controlled Kashmir, police said."A gunfight started between militants and joint contingents of police and paramilitary at Zadibal-Soura area of the city early today," a police spokesman said."The stand-off is underway."

 

Grazie per il tuo commento. Il tuo commento verrà pubblicato dopo essere stato esaminato.
Abbiamo riassunto questa notizia in modo che tu possa leggerla velocemente. Se sei interessato alla notizia puoi leggere il testo completo qui. Leggi di più:

 /  🏆 4. in İT

Italia Ultime Notizie, Italia Notizie